Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
961.72
1,129.22
702.97
858.36
989.45
985.65
924.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
961.72
1,129.22
702.97
858.36
989.45
985.65
924.26
Raw Material Cost
642.52
733.06
447.69
568.79
643.33
635.87
581.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.02
0.02
0.02
0.02
0.02
0.07
Selling and Distribution Expenses
123.41
143.44
123.24
145.54
134.64
166.51
179.03
Other Expenses
0.72
0.69
1.80
0.51
1.19
0.75
1.98
Total Expenditure (Excl Depreciation)
773.15
883.40
588.92
719.43
789.86
809.89
780.32
Operating Profit (PBDIT) excl Other Income
188.6
245.79999999999998
114
138.9
199.60000000000002
175.79999999999998
143.9
Other Income
13.95
10.78
50.17
26.80
24.14
81.18
58.62
Operating Profit (PBDIT)
220.86
276.28
53.31
186.70
243.14
278.97
110.29
Interest
0.02
0.02
0.02
0.02
0.02
0.02
0.07
Exceptional Items
31.97
-2.43
25.94
-0.87
0.06
-0.02
16.75
Gross Profit (PBDT)
319.19
396.17
255.28
289.57
346.12
349.78
342.87
Depreciation
29.80
29.80
29.75
29.75
29.59
29.59
34.18
Profit Before Tax
223.01
244.04
49.47
156.07
213.58
249.34
92.80
Tax
44.81
64.68
30.30
41.03
54.27
51.64
39.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
151.57
140.37
14.07
88.71
126.12
164.31
66.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
151.57
140.37
14.07
88.71
126.12
164.31
66.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
25.58
37.86
4.47
25.16
32.39
32.43
-14.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
177.15
178.23
18.55
113.87
158.51
196.74
51.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,512.64
6,455.93
6,315.57
6,351.81
6,264.55
6,342.03
6,173.66
Earnings per share (EPS)
0.11
0.1
0.01
0.06
0.09
0.12
0.05
Diluted Earnings per share
0.11
0.1
0.01
0.06
0.09
0.12
0.05
Operating Profit Margin (Excl OI)
18.42%
20.87%
-3.79%
15.16%
19.14%
17.06%
1.89%
Gross Profit Margin
26.29%
24.25%
11.27%
21.65%
24.58%
28.3%
13.74%
PAT Margin
15.76%
12.43%
2.0%
10.33%
12.75%
16.67%
7.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -14.83% vs 60.63% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -0.56% vs 863.24% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -22.07% vs 8,464.52% in Mar 2026
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Renhe Pharmacy Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
961.72
0
961.72
Other Operating Income
0.00
0.00
0.00
Total Operating income
961.72
0
961.72
Raw Material Cost
642.52
0
642.52
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
123.41
0
123.41
Other Expenses
0.72
0.00
0.72
Total Expenditure (Excl Depreciation)
773.15
0
773.15
Operating Profit (PBDIT) excl Other Income
188.56
0.00
188.56
Other Income
13.95
0
13.95
Operating Profit (PBDIT)
220.86
0
220.86
Interest
0.02
0
0.02
Exceptional Items
31.97
0
31.97
Gross Profit (PBDT)
319.19
0
319.19
Depreciation
29.80
0
29.80
Profit Before Tax
223.01
0
223.01
Tax
44.81
0
44.81
Provisions and contingencies
0
0
0.00
Profit After Tax
151.57
0
151.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
151.57
0
151.57
Share in Profit of Associates
0
0
0.00
Minority Interest
25.58
0
25.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
177.15
0
177.15
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,512.64
0
6,512.64
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
18.42%
0%
0.00
18.42%
Gross Profit Margin
26.29%
0%
0.00
26.29%
PAT Margin
15.76%
0%
0.00
15.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 96.17 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -14.83% vs 60.63% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -2.80% vs -11.28% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 17.72 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -0.56% vs 863.24% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 11.80% vs -21.88% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.69 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -22.07% vs 8,464.52% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -5.53% vs -24.40% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.42%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
